SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Partmann who wrote (1423)1/28/2002 4:24:51 PM
From: James C. Mc Gowan   of 10345
 
Bought back in to ELN, full position, at 38ish last week, and 33ish today; plus LEAPS S/P40 year2003

This opportunity doesn't come along that often, but with ELN you want to take advantage, IMHO.

Last full position buy for me was on Street.com and CSFB tag-teaming in behalf of shorts. Earnings per share were much lower then.

This inflammation on 4 patients, for a drug that would not yield profits, ex-benchmarks from partners on Alzeheimers med, for 3 to 4 years down the road, anyway, amounts to another overeaction buying opportunity. The Biotech index has also broken down recently, and that has not helped support any drug stock lately.

Good luck to all longs. I'm pleased to be a shareholder once again.
James
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News